Obsessive Compulsive Disorder research hub
4 indexed studies · 1 currently recruiting
- ongoing, recruitingTherapeutic confirmatory (Phase III)
A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Troriluzole in Obsessive Compulsive Disorder
This study is testing a new medicine, Troriluzole, for people with Obsessive-Compulsive Disorder (OCD). It compares Troriluzole to a dummy pill to see if it helps reduce OCD symptoms. This is a late-stage study, meaning it's one of the last steps before a medicine might become widely available.
Spain · Italy - ongoing, recruitingTherapeutic confirmatory (Phase III)
A Multicenter, Long-Term Open-Label Safety Study of Adjunctive Troriluzole in Subjects with Obsessive Compulsive Disorder
This study is looking at a new medicine called Troriluzole for people with Obsessive Compulsive Disorder (OCD). It's mainly checking how safe the medicine is over a long time when added to their usual treatment.
Italy · Spain - active not recruitingNA
Targeted Circuit-Based Transcranial Focused Ultrasound Intervention for Obsessive-Compulsive Disorder TUS-OCD
This study is testing a new, gentle brain stimulation called focused ultrasound (TUS) for people with Obsessive-Compulsive Disorder (OCD). Researchers want to see if it's safe and helps reduce OCD symptoms by targeting specific brain areas involved in the condition.
United Kingdom - recruiting
Neural Mechanisms of Obsessive-compulsive Disorder (OCD) Treatment Failure
This study aims to understand why some people with Obsessive-Compulsive Disorder (OCD) don't get better with talking therapies. Researchers will look at how the brain works during therapy to find ways to improve treatment for everyone.
United Kingdom